Skip to content

Opko Health OPK Interest Paid

Interest Paid at other companies

HRO
HarrowHROW
$10.96M+71.5%
Precigen logo
PrecigenPGEN
$2.56M
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$56.45M+0.2%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$97K0.0%
ALN
Alnylam PharmaceuticalsALNY
$64.2M-6.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$90K-2.2%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B-22.4%
P/S1.9×-0.2×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's interest paid?
Opko Health (OPK) reported interest paid of $9.6M in Q1 2026.
How has Opko Health's interest paid changed year-over-year?
Opko Health's interest paid decreased by 30.2% year-over-year, from $13.76M to $9.6M.
What is the long-term trend for Opko Health's interest paid?
Over 3 years (2021 to 2025), Opko Health's interest paid has grown at a 64.5% compound annual growth rate (CAGR), from $8.52M to $37.94M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.